academic article

• Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease..  Brain sciences.  14. 2024
• Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease..  PLoS ONE.  11:-. 2016
• Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease..  Movement disorders clinical practice.  3:257-267. 2015